IMAC (IMACW) Stock Price, News & Analysis

Company Overview

the imac regeneration center is an integrative medicine clinic serving patients with knee pain, back pain, soft tissue and joint damage, muscular tears, and arthritis. we earn patients based on successful outcomes of previous guests. it is our sincere goal to provide each patient with non-invasive treatments that result in a quality, pain-free life. we have proven that there is an alternative to knee replacements, hip replacements, spinal fusion surgery, and ligament transplants. our proprietary procedures have been trusted by patients ranging from professional athletes to independent seniors.

Key Stats

• Today's Range: $0.0051 to $0.0133
• 50-Day Range: $0.00 to $0.09
• 52-Week Range: $0.00 to $0.17
• Volume: 45,294 shs
• Average Volume: 72,375 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IMACW Stock Analysis - Frequently Asked Questions

When did IMAC IPO?

IMAC (IMACW) raised $0 in an IPO on the week of February 11th 2019. The company issued 1,700,000 shares at $0.00 per share. Dawson James Securities and Cuttone acted as the underwriters for the IPO.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Outpatient Mental Health & Substance Abuse Centers
• Sub-Industry: N/A
• Current Symbol: NASDAQ:IMACW
• CIK: 1729944
• Web: imacregeneration.com
• Phone: 18442664622
• Fax: N/A
• Employees: 58
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $8.47 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A